1. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma
   Daniel N. Dang et al, 2015, Human Pathology CrossRef
2. Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy
   Ying L. Liu et al, 2016, Breast Cancer Research and Treatment CrossRef
3. Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review
   Nadine S. van den Ende et al, 2023, International Journal of Molecular Sciences CrossRef
4. Correlation of L‐type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis
   Mio Furuya et al, 2012, Cancer Science CrossRef
5. Novel biomarkers in triple-negative breast cancer - role and perspective
   Manzoor A. Mir et al, 2022, Combinational Therapy in Triple Negative Breast Cancer CrossRef
6. Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells
   Pallabita Chowdhury et al, 2019, Journal of Colloid and Interface Science CrossRef
7. Impact of TP53 mutations in Triple Negative Breast Cancer
   Zahi I. Mitri et al, 2022, npj Precision Oncology CrossRef
8. New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
   Brahim El Hejjioui et al, 2023, Diagnostics CrossRef
9. Recent therapeutic trends and promising targets in triple negative breast cancer
   Soo-Yeon Hwang et al, 2019, Pharmacology & Therapeutics CrossRef
10. A Nomogram to Predict the Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Laboratory Indicators
    Fanrong Zhang et al, 2019, Annals of Surgical Oncology CrossRef
11. Herbal Medicine: Prejudice to Realm of Reality Against TNBC
    Balachandran S. Vinod et al, 2023, Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer CrossRef
12. Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer
    Jean Ogier du Terrail et al, 2023, Nature Medicine CrossRef
13. Prediction of Treatment Response in Triple Negative Breast Cancer From Whole Slide Images
    Peter Naylor et al, 2022, Frontiers in Signal Processing CrossRef
14. Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    Taeryung Kim et al, 2015, Journal of Breast Cancer CrossRef
15. The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis
    Fausto Petrelli et al, 2014, Breast Cancer Research and Treatment CrossRef
16. Genetic Markers in Triple-Negative Breast Cancer
    Zuzana Sporikova et al, 2018, Clinical Breast Cancer CrossRef